Research on Clinical Treatment Strategy and Mechanism of Parkinson's Disease Based on Nourishing Kidney and Activating Blood

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058725

Enrollment

Unknown

Registered

2022-04-15

Start date

2022-04-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Treatment group:Bushen huoxue granule

Control group:Madopar

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the western diagnostic criteria of PD; 2. Hoehn&Y ahr scale grade = 4; 3. PD course = 15 years; 4. Aged from 60 to 80; 5. Volunteer to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Accompanied with major diseases such as severe liver and kidney dysfunction, severe infection, etc; 2. People with allergic constitution; 3. Patients who have participated in other clinical studies in the past three months.

Design outcomes

Primary

Measure	Time frame
Updrs scale;	—

Countries

China

Contacts

Public ContactYang Minghui

Chinese PLA General Hospital

ymh9651@sina.com+86 10 66939651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026